| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |